Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma – Results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience
Titel:
Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma – Results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience
Auteur:
Weeda, V.B. Murawski, M. McCabe, A.J. Maibach, R. Brugières, L. Roebuck, D. Fabre, M. Zimmermann, A. Otte, J.B. Sullivan, M. Perilongo, G. Childs, M. Brock, P. Zsíros, J. Plaschkes, J. Czauderna, P. Aronson, D.C.